Chronic Kidney Disease and Coronary Artery Disease
Mark J. Sarnak(Tufts Medical Center), Rukshana Shroff(Great Ormond Street Hospital), Charumathi Sabanayagam(Singapore National Eye Center), Mark A. Hlatky(Cardiovascular Institute of the South), Krista L. Lentine(Saint Louis University Hospital), Wolfgang C. Winkelmayer(Palo Alto University), Paolo Raggi(University of Alberta), Gautam R. Shroff, Tara I. Chang, Patrick Rossignol(Inserm), Hideki Ishii(Gunma University), Mohamed Marwan(Friedrich-Alexander-Universität Erlangen-Nürnberg), Josiah Ruturi, Günther Laufer(Medical University of Vienna), Roberto Pecoits‐Filho(Pontifícia Universidade Católica do Paraná), Jonathan C. Craig(Flinders University), João L. Cavalcante(Minneapolis Heart Institute Foundation), Charmaine E. Lok(University Health Network), Gérard M. London(Unknown), L. Kristin Newby(Duke University), Patrick B. Mark(Queen Elizabeth University Hospital), Michael Cheung(National Kidney Foundation), Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Kerstin Amann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Marcello Rattazzi, Yuxin Nie, Sripal Bangalore(New York University), Kevin W. Lobdell, Xiaoqiang Ding(China Academy of Safety Sciences and Technology), Catherine M. Shanahan(King's College London), Carlo Briguori, David C. Wheeler(University College London), Nicole M. Isbel(The University of Queensland), Christopher R. deFilippi, Alan G. Jardine(Western Infirmary), Charles A. Herzog, Thomas H. Marwick(The University of Queensland), Ulf Landmesser(Deutsches Herzzentrum der Charité), Jolanta Małyszko, Philip A. Kalra(University of Manchester), Debasish Banerjee(Toyota Motor Corporation (Switzerland)), David M. Charytan(NYU Langone Health), Chien‐Liang Chen, John S. Gill(University of British Columbia), Meg Jardine(Royal North Shore Hospital), Wajeh Y. Qunibi, Patrick S. Parfrey, Helen Pilmore, Jagbir Gill(University of British Columbia), Mario Gössl(Abbott Northwestern Hospital)
Cited by 716
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k